ALPS Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-968
| Closed | -$319K | – | 1147 |
|
|
2024
Q2 | $319K | Sell |
968
-2
| -0.2% | -$659 | ﹤0.01% | 817 |
|
|
2024
Q1 | $384K | Buy |
+970
| New | +$384K | ﹤0.01% | 654 |
|
|
2023
Q3 | – | Sell |
-1,009
| Closed | -$386K | – | 1141 |
|
|
2023
Q2 | $386K | Buy |
1,009
+5
| +0.5% | +$1.91K | ﹤0.01% | 668 |
|
|
2023
Q1 | $348K | Sell |
1,004
-71
| -7% | -$24.6K | ﹤0.01% | 685 |
|
|
2022
Q4 | $253K | Sell |
1,075
-10
| -0.9% | -$2.35K | ﹤0.01% | 960 |
|
|
2022
Q3 | $267K | Buy |
1,085
+190
| +21% | +$46.8K | ﹤0.01% | 957 |
|
|
2022
Q2 | $271K | Buy |
+895
| New | +$271K | ﹤0.01% | 895 |
|
|
2022
Q1 | – | Sell |
-820
| Closed | -$385K | – | 996 |
|
|
2021
Q4 | $385K | Buy |
820
+16
| +2% | +$7.51K | ﹤0.01% | 705 |
|
|
2021
Q3 | $341K | Sell |
804
-433
| -35% | -$184K | ﹤0.01% | 789 |
|
|
2021
Q2 | $444K | Hold |
1,237
| – | – | ﹤0.01% | 540 |
|
|
2021
Q1 | $349K | Buy |
1,237
+307
| +33% | +$86.6K | ﹤0.01% | 592 |
|
|
2020
Q4 | $263K | Sell |
930
-19
| -2% | -$5.37K | ﹤0.01% | 794 |
|
|
2020
Q3 | $261K | Sell |
949
-467
| -33% | -$128K | ﹤0.01% | 707 |
|
|
2020
Q2 | $322K | Sell |
1,416
-156
| -10% | -$35.5K | ﹤0.01% | 538 |
|
|
2020
Q1 | $239K | Sell |
1,572
-870
| -36% | -$132K | ﹤0.01% | 615 |
|
|
2019
Q4 | $367K | Sell |
2,442
-105
| -4% | -$15.8K | ﹤0.01% | 668 |
|
|
2019
Q3 | $361K | Buy |
+2,547
| New | +$361K | ﹤0.01% | 630 |
|
|
2018
Q4 | – | Sell |
-1,886
| Closed | -$233K | – | 952 |
|
|
2018
Q3 | $233K | Buy |
+1,886
| New | +$233K | ﹤0.01% | 917 |
|
|
2018
Q1 | – | Sell |
-2,088
| Closed | -$206K | – | 1002 |
|
|
2017
Q4 | $206K | Buy |
+2,088
| New | +$206K | ﹤0.01% | 822 |
|